Keywords
How to Cite
Abstract
The article presents the experience of working of professional surgeons and endocrinologists for ways to optimize the treatment of ulcer-necrotic foot defects, complicated by phlegmons and osteomyelitis. It had been studied two groups of patients with clinical type 2 diabetes with purulent-necrotic foot defects – the primary group (59 persons) and the control group (63 persons). 122 patients with neuropathic and neuro-ischemic forms of diabetic foot (III and IV stage of the process by Wagner) were operated on in both groups. The scheme of post-operative treatment of 59 patients of the primary group contained an intravenous drip of α-lipoic acid as a drug Dialipon® at a dose of 1200 mg/day for 20 days. So optimized surgical method of treatment and the expansion of indications for use of the drug Dialipon® in the postoperative period in patients with purulent-necrotic presentations of diabetic foot helped to reduce the period of healing of postoperative wounds in the primary group of patients up to 28-30 days, whereas in the control group, the healing time were 56-60 days. The developed algorithm and the scheme of complex surgical treatment of these patients allowed to minimize the number of high amputations and increased by 40% the number of distal amputations of the foot, and thus it helped to keep the foot bearing function in 92% of cases.
References
2. Гурьева И.В. Профилактика, лечение, медико-социальная реабилитация и организация междисциплинарной помощи больным с синдромом диабетической стопы: Дис…д-ра мед.наук. – М. – 2001.
3. Гурьева И.В., Кузина И.В., Воронин А.В., Комелягина Е.Ю., Мамонтова Е.Ю. Синдром диабетической стопы. Методические рекомендации – М. – 2000.— 40 с.
4. Болгарська С.В. Диференційно-діагностичні особливості та підхід до лікування трофічних виразок нижніх кінцівок у хворих на цукровий діабет: Автореф. Дис...канд.мед.наук: 14.01.14. / ДУ «Інститут ендокринології та обміну речовин ім. В.П. Комісаренка АМН України». – К. – 2004. – 17 с.
5. Скибун В.Н. Патогенетические аспекты терапии нейропатической формы синдрома диабетической стопы: Автореф. Дис...канд.мед. наук: 14.01.14. / ДУ «Інститут ендокринології та обміну речовин ім. В.П. Комісаренка АМН України». – К. – 2003. – 17 с.
6. Международное Соглашение по диабетической стопе. – 2000.
7. Clinical Guidelines for Type 2 Diabetes UK.
8. Jesudason E.P., Masilamoni J.G., Jebaraj C.E. et al. Efficacy of DL-alpha lipoic acid against systemic inflammation-induced mice: antioxidant defense system. Mol Cell Biochem. – 2008 Jun. – 313(1–2): S. 113–23.
9. Boulton A.J.M. International collaboration on the diabetic foot: a 15-year progress report // Diabet. Metab. Res. Rev. – 2004.– Vol. 20, supp.1. – P. 2-3.
10. International Consensus for Wound healing and treatments for people with diabetic foot ulcers. – Diabetes Metab. Res. Rev. – 2007. – 20 (supp. 1). – P. 78-89.